Progastrin overexpression imparts tumorigenic/metastatic potential to embryonic epithelial cells: Phenotypic differences between transformed and nontransformed stem cells

International Journal of Cancer

Volumn 131, Issue 7, 2012, Pages

  Sarkar, Shubhashish ^a   Kantara, Carla ^a,b   Ortiz, Ixiu ^a   Swiercz, Rafal ^a,b   Kuo, Joyce ^a   Davey, Robert ^a   Escobar, Kenneth ^a   Ullrich, Robert ^b   Singh, Pomila ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

catenin; annexinA2; CD44; DCLK1; stem cells

Indexed keywords

BETA CATENIN; CELL MARKER; DCLK1 PROTEIN; HERMES ANTIGEN; LGR5 PROTEIN; LIPOCORTIN 2; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; PROGASTRIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CARCINOGENESIS; CELL CLONE; CELL PROLIFERATION; CELL SELECTION; CELL SHAPE; CELL STRUCTURE; CELL TRANSFORMATION; DOWN REGULATION; EMBRYO; EMBRYO CELL; EPITHELIUM CELL; FLUORESCENCE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; XENOGRAFT;

ANIMALS; ANNEXIN A2; ANTIGENS, CD44; BETA CATENIN; BIOLOGICAL MARKERS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; GASTRINS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MICE, NUDE; MICE, SCID; NEOPLASM METASTASIS; PHENOTYPE; PROTEIN PRECURSORS; PROTEIN-SERINE-THREONINE KINASES; SPHEROIDS, CELLULAR; STEM CELLS;

EID: 84864430591     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27615     Document Type: Article

References (47)

1. Rengifo-Cam W, Singh P,. Role of progastrins/gastrins and their receptors in GI and pancreatic cancers: targets for treatment. Curr Pharm Des 2004; 10: 2345-58.
2. Singh P, Owlia A, Varro A, et al. Gastrin gene expression is required for proliferation and tumorigenicity of human colon-cancer-cells. Cancer Res 1996; 56: 4111-15.
3. Smith JP, Verderame MF, Ballard EN, et al. Functional significance of gastrin gene expression in human cancer-cells. Regul Pept 2004; 117: 167-73.
4. Wang TC, Koh TJ, Varro A, et al. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 1996; 98: 1918-29.
5. Baldwin GS, Hollande F, Yang Z, et al. Biologically active human progastrin(6-80) contains a tightly bound calcium ion. J Biol Chem 2001; 276: 7791-96.
6. Singh P, Lu X, Cobb S, et al. Progastrin1-80 stimulates growth of intestinal epithelial cells in vitro via high-affinity binding sites. Am J Physiol 2003; 284: G328-G339.
7. Rengifo-Cam W, Umar S, Sarkar S, et al. Anti-apoptotic effects of progastrin on pancreatic cancer-cells are mediated by sustained activation of nuclear-factor-{kappa}B. Cancer Res 2007; 67: 7266-74.
8. Singh P, Velasco M, Given R, et al. Progastrin expression predisposes mice to colon carcinomas in response to chemical carcinogen. Gastroenterology 2000; 119: 162-71.
9. Cobb S, Wood T, Ceci J, et al. Intestinal expression of mutant and wild-type progastrin increases colon-carcinogenesis in response to azoxymethane in transgenic mice. Cancer 2004; 100: 1311-23.
10. Jin G, Ramanathan V, Quante M, et al. Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic-crypt fission, proliferation, and colorectal-cancer in mice. J Clin Invest 2009; 119: 2691-701.
11. Singh P, Wu H, Clark C, et al. AnnexinII binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon-cancer and intestinal-epithelial-cells. Oncogene 2007; 26: 425-40.
12. Sarkar S, Swiercz R, Kantara C, et al. AnnexinA2 mediates up-regulation of NF-κB, β-catenin, and stem-cells in response to progastrin in mice and HEK-293 cells. Gastroenterology 2011; 140: 583-95.
13. Sarkar S, Singh P,. Endosomal translocation of progastrin/annexinII is required for measuring activation of p38MAPK/ERK/NFκBp65 in IEC-18 cells. Gastroenterology 2009; 138 (Suppl 1): S1987.
14. Díaz VM, Hurtado M, Thomson TM, et al. Specific interaction of tissue-type plasminogen activator with annexinII on membranes of pancreatic cancer-cells activates plasminogen and promotes invasion in vitro. Gut 2004; 53: 993-1000.
15. Sharma M, Ownbey RT, Sharma MC,. Breast cancer cell-surface annexinII induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Exp Mol Pathol 2010; 88: 278-86.
16. Zheng L, Foley K, Huang L, et al. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexinA2 is required for invasion and metastases of pancreatic cancer. PLoS One 2011; 6: e19390.
17. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003; 17: 1253-70.
18. Zhao P, Zhang W, Tang J, et al. Annexin II promotes invasion and migration of human hepatocellular-carcinoma-cells in vitro via its interaction with HAb18G/CD147. Cancer Sci 2010; 101: 387-95.
19. Ottewell PD, Varro A, Dockray GJ, et al. COOH-terminal 26 amino-acid residues of progastrin are sufficient for stimulation of mitosis in murine colonic epithelium in vivo. Am J Physiol 2005; 288: G541-G549.
20. Kesavan K, Ratliff J, Johnson EW, et al. AnnexinA2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects. J Biol Chem 2010; 285: 4366-74.
21. Barker N, Clevers H,. Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells. Gastroenterology 2010; 138: 1681-96.
22. Sureban SM, May R, Ramalingam S, et al. Selective blockade of DCAMKL-1 results in tumor growth arrest by Let-7a MicroRNA-dependent mechanism. Gastroenterology 2009; 13: 649-59.
23. Sureban SM, May R, Lightfoot SA, et al. DCAMKL-1 regulates epithelial-mesenchymal-transition in human pancreatic cells through miR-200a-dependent mechanism. Cancer Res 2011; 71: 2328-38.
24. Singh P, Sarkar S, Umar S, et al. Insulin-like growth factors are more effective than progastrin in reversing proapoptotic effects of curcumin: critical role of p38MAPK. Am J Physiol 2010; 298: G551-G562.
25. Singh P,. Role of annexinII in GI cancers: interaction with gastrins/progastrins. Cancer Lett 2007; 252: 19-35.
26. Ma AS, Bel DJ, Mittal AA, et al. Immunocytochemical detection of extracellular-annexinII in cultured human skin keratinocytes and isolation of annexinII isoforms enriched in extracellular pool. J Cell Sci 1994; 107: 1973-84.
27. Esposito I, Penzel R, Chaib-Harrireche M, et al. Tenascin-C and annexinII expression in the process of pancreatic carcinogenesis. J Pathol 2006; 208: 673-85.
28. Sharma MC, Sharma M,. Role of annexinII in angiogenesis and tumor progression: a potential therapeutic target. Curr Pharm Des 2007; 13: 3568-75.
29. Valapala M, Vishwanatha JK,. Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexinA2. J Biol Chem 2011; 286: 30911-25.
30. Ji NY, Park MY, Kang YH, et al. Evaluation of annexin II as a potential serum-marker for hepatocellular-carcinoma using a sandwich ELISA method. Int J Mol Med 2009; 24: 765-71.
31. Sarkar S, Maxwell CA, Luthra G, et al. AnnexinA2 is increasingly expressed and released into serum of patients positive for colonic growths in relation to disease progression: diagnostic implications. Gastroenterology 2011; 140 (Suppl 1): S341.
32. Patchell BJ, Wojcik KR, Yang TL, et al. Glycosylation and annexinII cell-surface translocation mediates airway epithelial wound repair. Am J Physiol 2007; 293: L354-L363.
33. Brumlik MJ, Daniel BJ, Waehler R, et al. Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy. Expert Opin Drug Deliv 2008; 5: 87-103.
34. Ferrand A, Bertrand C, Portolan G, et al. Signaling pathways associated with colonic mucosa hyperproliferation in mice overexpressing gastrin-precursors. Cancer Res 2005; 65: 2770-7.
35. Umar S, Sarkar S, Cowey S, et al. Activation of NF-κB is required for mediating proliferative/anti-apoptotic effects of progastrin on proximal colonic-crypts of mice, in vivo. Oncogene 2008; 27: 5599-611.
36. Umar S, Sarkar S, Wang Y, et al. Functional cross-talk between beta-catenin and NFκB signaling pathways in colonic-crypts of mice in response to progastrin. J Biol Chem 2009; 284: 22274-84.
37. Pannequin J, Bonnans C, Delaunay N, et al. The Wnt target jagged-1 mediates activation of notch signaling by progastrin in human colorectal-cancer-cells. Cancer Res 2009; 9: 6065-73.
38. Misra S, Heldin P, Hascall VC, et al. Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J 2011; 278: 1429-43.
39. McVoy LA, Kew RR,. CD44 and annexinA2 mediate C5a chemotactic cofactor function of vitamin D binding protein. J Immunol 2005; 175: 4754-60.
40. Yu Q, Stamenkovic I,. Localization of matrix-metalloproteinase-9 to cell-surface provides mechanism for CD44-mediated tumor invasion. Genes Dev 1999; 13: 35-48.
41. Reeder JA, Gotley DC, Walsh MD, et al. Expression of antisense CD44-variant6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Cancer Res 1998; 58: 3719-26.
42. Ling Q, Jacovina AT, Deora A, et al. AnnexinII regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest 2004; 113: 38-48.
43. Longerich T, Haller MT, Mogler C, et al. AnnexinA2 as a differential diagnostic marker of hepatocellular-tumors. Pathol Res Pract 2011; 207: 8-14.
44. Walker F, Zhang HH, Odorizzi A, et al. LGR5 is a negative regulator of tumorigenicity, antagonizes Wnt signaling and regulates cell-adhesion in colorectal-cancer-cell lines. PLoS One 2011; 6: e22733.
45. Kemper K, Grandela C, Medema JP,. Molecular identification and targeting of colorectal cancer-stem-cells. Oncotarget 2010; 1: 387-95.
46. Shu T, Tseng HC, Sapir T, et al. Doublecortin-like-kinase controls neurogenesis by regulating mitotic spindles and M phase progression. Neuron 2006; 49: 25-39.
47. Verissimo CS, Molenaar JJ, Meerman J, et al. Silencing of microtubule-associated proteins doublecortin-like and doublecortin-like kinase-long induces apoptosis in neuroblastoma. Endocr Relat Cancer 2010; 17: 399-414.